‘Questions from readers about EUA Countermeasures’; by SASHA LATYPOVA; once again Sasha opens our eyes more clearly on the fraud of COVID, the non-pandemic it was & how much corruption there is

in declaring a public health emergency by the HHS Secretary, how the response is classified as countermeasures, and how much this was a military response and not a public health response

Due Diligence and Art

Questions from readers about EUA Countermeasures

Question from Meryl Nass referring to the statement in my “Summary of Everything” that EUA countermeasures could not be tested for safety or efficacy in accordance with US law (21 CFR 312 and 21 CFR 601), nor could compliance with current Good Manufacturing Practices (cGMP) or Good Distribution Practices (GxP in general) be enforced by the FDA due to the statutor…
Read more
3 days ago · 37 likes · 8 comments · Sasha Latypova

How did he know?
‘Step 0: DOD identifies obesity virus by scouring remote caves in Southeast Asia for bat and pangolin droppings, then designates this virus a national security threat after PCR-ing a handful of cases in the US. Robert Malone writes a 100 page book on “how to prepare for obesity virus pandemic” in 3 weeks. Boom. We are good to go!’

‘Question from

Dr. Paul Alexander’s Newsletter_Alexander News Network is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Meryl Nass
referring to the statement in my“Summary of Everything”that EUA countermeasures could not be tested for safety or efficacy in accordance with US law (21 CFR 312 and 21 CFR 601), nor could compliance with current Good Manufacturing Practices (cGMP) or Good Distribution Practices (GxP in general) be enforced by the FDA due to the statutory “non-investigational” nature of EUA products. Non-investigational status precludes the possibility of a clinical investigation (human trial).
Meryl Nass
Due Diligence and Art is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Upgrade to paid
Meryl’s COVID Newsletter
Aug 7, 2023

Sasha, I am not sure about #7. It depends when the vaccines were designated as “covered countermeasures.” While there are general declarations in the Federal Register about types of products designated as covered countermeasures by the HHS Secretary, I suspect there are specific designations for specific products somewhere else. Otherwise you or I could claim we have a drug or vaccine against COVID, and it would obtain the “covered countermeasure” designation. HCQ would be a covered countermeasure, for instance.

If the vaccines were designated as CCs only when authorized, then they could have undergone clinical trials before then.

I am sorry, I didn’t see this question until now. I get a lot of notifications and simply do not see many questions or comments. It is a good question, asked by many people. Here is the answer:
Covid “vaccines” were designated as EUA countermeasures at the latest by October 22, 2020. In fact, I believe Pfizer switched to the EUA by July 2020, as they started mass commercial manufacturing of their vaccines in August 2020 (this would have been illegal under IND, but is legal for EUA). Here is the transcript from the FDA meeting on that date clearly saying so:

Doran Fink says Emergency Use Authorization is their regulatory pathway, and not the Expanded Access Use. The EUA exists ONLY under PREP Act, and ONLY as a countermeasure. Here is a powerpoint from the FDA lawyers discussing this.
How this works in practice:
You or I can claim we have a vaccine against obesity and, claim that since obesity is a dangerous global pandemic, our vaccine should be designated as a EUA countermeasure. I am going to describe the entire regulatory pathway for having something designated as an EUA countermeasure. It consists of 2 steps:
Step 1: Xavier Becerra (or his successor) SAYS that there is a pandemic of obesity caused by a virus. He can also say there is a potential for pandemic of obesity caused by a virus – that is the minimum he needs to claim to declare a pandemic.
Step 2. Xavier (or his successor) SAYS our vaccine product is a countermeasure for this pandemic of obesity.
Step 0: DOD identifies obesity virus by scouring remote caves in Southeast Asia for bat and pangolin droppings, then designates this virus a national security threat after PCR-ing a handful of cases in the US. Robert Malone writes a 100 page book on “how to prepare for obesity virus pandemic” in 3 weeks. Boom. We are good to go!
The end. Product gets issued an EUA, and as long as Xavier or his successor can claim there is a potential for an obesity pandemic, we are good. The government will be buying and stockpiling our obesity vaccine in the Strategic National Stockpile and CDC will put it on the childhood schedule. Isn’t this great?

Ask me how to convince Xavier to say there is a pandemic of purple unicorns and my purple unicorn spray is a safe and effective EUA countermeasure, and the US government should purchase $10 billion worth of it. I think we all know how to make Xavier say so.
Additional questions from readers:

Why is the FDA issuing Emergency Use Authorizations for fully approved “vaccines”?

“On September 11, 2023, the Food and Drug Administration (FDA) approved the updated (2023–2024 Formula) COVID-19 mRNA vaccines by Moderna and Pfizer-BioNTech for persons aged ≥12 years and authorized these vaccines for persons aged 6 months–11 years under Emergency Use Authorization (EUA). On October 3, 2023, FDA authorized the updated COVID-19 vaccine by Novavax for use in persons aged ≥12 years under EUA.”

https://www.cdc.gov/mmwr/volumes/72/wr/mm7242e1.htm

This gets to the FDA saying that “approved” and EUA versions can co-exist. It is true that an investigational product, previously FDA approved using an investigational pathway (e.g. HCQ or IVM) can be used as a EUA countermeasure under declared emergency. However, any FDA approved product can be used off-label if a physician thinks it may be effective (because a full legal investigational approval process, conducted in compliance with FDCA had previously concluded that it is generally safe). That’s a physician’s discretion due to their medical training and licensing (not a lawyer’s discretion in case of Xavier Becerra).
However, an FDA-approved product can only exist if an investigational drug or device, has undergone a full set of prescribed pre-clinical and clinical testing and the manufacturer has complied with the cGxP while being subject to the IRB, informed consent and other requirements put on the investigational products by the FDCA. That has NEVER happened for covid injections.
What FDA is claiming -”full approval” for covid vaxxes – is an impossibility. It is the same impossibility as getting pregnant, having an abortion and several months later giving birth to the same baby. Not possible.
Getting pregnant = opening IND with the FDA by the manufacturer;
Having an abortion = switch to the EUA non-investigational status;
Claiming several months later the birth of a healthy full term baby = FDA issues BLA approval for covid vaxxes based on the clinical trials that switched to a non-investigational status and were never completed.
That’s why, the FDA’s “full approval” is a lie, a fig leaf. That’s why they keep issuing the EUAs while they claim they are “approved”. The FDA is certifying this fraud.
Art for today: Dragon, watercolor.’

Dr. Paul Alexander’s Newsletter_Alexander News Network is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Go to Dr Alexancer on Substack
Author: Dr. Paul Alexander